Edwards Lifesciences Corporation Other Comprehensive Income (Loss), before Reclassifications, before Tax
Edwards Lifesciences Corporation (EW) reported Other Comprehensive Income (Loss), before Reclassifications, before Tax of $39.80 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax · last filed 2026-05-06
- Edwards Lifesciences Corporation other comprehensive income (loss), before reclassifications, before tax for the quarter ending 2026-03-31 was $39.80M, a 476.81% increase year-over-year.
- Edwards Lifesciences Corporation other comprehensive income (loss), before reclassifications, before tax for the quarter ending 2025-09-30 was $36.70M.
- Edwards Lifesciences Corporation other comprehensive income (loss), before reclassifications, before tax for the quarter ending 2025-06-30 was -$2.70M, a 109.22% decline year-over-year.
- Edwards Lifesciences Corporation other comprehensive income (loss), before reclassifications, before tax for the quarter ending 2025-03-31 was $6.90M, a 74.91% decline year-over-year.
- Edwards Lifesciences Corporation other comprehensive income (loss), before reclassifications, before tax for fiscal 2018 was $2.90M, a 93.10% decline from fiscal 2017.
- Edwards Lifesciences Corporation other comprehensive income (loss), before reclassifications, before tax for fiscal 2017 was $42.00M.
- Edwards Lifesciences Corporation other comprehensive income (loss), before reclassifications, before tax for fiscal 2016 was -$8.50M.
- Edwards Lifesciences Corporation other comprehensive income (loss), before reclassifications, before tax for fiscal 2015 was -$25.90M.
| Period end | Other Comprehensive Income (Loss), before Reclassifications, before Tax 3 month | Other Comprehensive Income (Loss), before Reclassifications, before Tax 6 month | Other Comprehensive Income (Loss), before Reclassifications, before Tax 9 month | Other Comprehensive Income (Loss), before Reclassifications, before Tax 12 month |
|---|---|---|---|---|
| 2026-03-31 | $39.80M 10-Q · filed 2026-05-06 | |||
| 2025-09-30 | $36.70M 10-Q · filed 2025-11-05 | $34.00M derived: sum of 2 quarters · filed 2025-11-05 | $40.90M derived: sum of 3 quarters · filed 2026-05-06 | |
| 2025-06-30 | -$2.70M 10-Q · filed 2025-11-05 | $4.20M derived: sum of 2 quarters · filed 2026-05-06 | ||
| 2025-03-31 | $6.90M 10-Q · filed 2026-05-06 | |||
| 2024-09-30 | -$30.40M 10-Q · filed 2025-11-05 | -$1.10M derived: sum of 2 quarters · filed 2025-11-05 | $26.40M derived: sum of 3 quarters · filed 2025-11-05 | |
| 2024-06-30 | $29.30M 10-Q · filed 2025-11-05 | $56.80M derived: sum of 2 quarters · filed 2025-11-05 | ||
| 2024-03-31 | $27.50M 10-Q · filed 2025-11-05 | |||
| 2019-09-30 | $25.00M 10-Q · filed 2019-10-25 | |||
| 2019-03-31 | $9.70M 10-Q · filed 2019-04-26 | $23.90M derived: sum of 2 quarters · filed 2019-04-26 | $33.90M derived: sum of 3 quarters · filed 2019-04-26 | $6.00M derived: sum of 4 quarters · filed 2019-04-26 |
| 2018-12-31 | $14.20M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $24.20M derived: sum of 2 quarters · filed 2019-02-15 | -$3.70M derived: sum of 3 quarters · filed 2019-02-15 | $2.90M 10-K · filed 2019-02-15 |
| 2018-09-30 | $10.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | -$17.90M derived: sum of 2 quarters · filed 2018-10-26 | -$11.30M 10-Q · filed 2018-10-26 | $200.00K derived: sum of 4 quarters · filed 2019-02-15 |
| 2018-06-30 | -$27.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | -$21.30M 10-Q · filed 2018-07-27 | -$9.80M derived: sum of 3 quarters · filed 2019-02-15 | -$5.30M derived: sum of 4 quarters · filed 2019-02-15 |
| 2018-03-31 | $6.60M 10-Q · filed 2018-04-27 | $18.10M derived: sum of 2 quarters · filed 2019-02-15 | $22.60M derived: sum of 3 quarters · filed 2019-02-15 | $34.50M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-12-31 | $11.50M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $16.00M derived: sum of 2 quarters · filed 2019-02-15 | $27.90M derived: sum of 3 quarters · filed 2019-02-15 | $42.00M 10-K · filed 2019-02-15 |
| 2017-09-30 | $4.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | $16.40M derived: sum of 2 quarters · filed 2017-10-27 | $30.50M 10-Q · filed 2017-10-27 | $17.10M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-06-30 | $11.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | $26.00M 10-Q · filed 2017-07-28 | $12.60M derived: sum of 3 quarters · filed 2019-02-15 | |
| 2017-03-31 | $14.10M 10-Q · filed 2017-04-28 | $700.00K derived: sum of 2 quarters · filed 2019-02-15 | ||
| 2016-12-31 | -$13.40M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | -$8.50M 10-K · filed 2019-02-15 | ||
| 2016-09-30 | $4.90M 10-Q · filed 2016-10-28 | |||
| 2015-12-31 | $3.60M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | -$8.00M derived: sum of 2 quarters · filed 2018-02-16 | $2.20M derived: sum of 3 quarters · filed 2018-02-16 | -$25.90M 10-K · filed 2018-02-16 |
| 2015-09-30 | -$11.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | -$1.40M derived: sum of 2 quarters · filed 2015-10-29 | -$29.50M 10-Q · filed 2015-10-29 | -$51.30M derived: sum of 4 quarters · filed 2016-02-19 |
| 2015-06-30 | $10.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-29 | -$17.90M 10-Q · filed 2015-07-29 | -$39.70M derived: sum of 3 quarters · filed 2016-02-19 | -$56.80M derived: sum of 4 quarters · filed 2016-02-19 |
| 2015-03-31 | -$28.10M 10-Q · filed 2015-04-29 | -$49.90M derived: sum of 2 quarters · filed 2016-02-19 | -$67.00M derived: sum of 3 quarters · filed 2016-02-19 | -$75.30M derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-12-31 | -$21.80M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | -$38.90M derived: sum of 2 quarters · filed 2016-02-19 | -$47.20M derived: sum of 3 quarters · filed 2016-02-19 | -$49.80M 10-K · filed 2016-02-19 |
| 2014-09-30 | -$17.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | -$25.40M derived: sum of 2 quarters · filed 2014-10-31 | -$28.00M 10-Q · filed 2014-10-31 | -$9.00M derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-06-30 | -$8.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | -$10.90M 10-Q · filed 2014-08-04 | $8.10M derived: sum of 3 quarters · filed 2016-02-19 | |
| 2014-03-31 | -$2.60M 10-Q · filed 2014-05-02 | $16.40M derived: sum of 2 quarters · filed 2016-02-19 | ||
| 2013-12-31 | $19.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $30.60M 10-K · filed 2016-02-19 | ||
| 2013-09-30 | $11.60M 10-Q · filed 2013-11-07 | |||
| 2012-12-31 | $10.20M 10-K · filed 2015-02-20 | |||
| 2011-12-31 | -$14.40M 10-K · filed 2014-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |